ARTICLE | Company News
Galapagos, GlaxoSmithKline deal
August 9, 2010 7:00 AM UTC
Galapagos reacquired all rights to GLPG0634 for an undisclosed amount from GlaxoSmithKline, which had an option under an ongoing 2006 deal to license the arthritis candidate after Phase IIa testing. ...